Register by July 10, 2009 and SAVE! up to $350
| Cambridge Healthtech Institute is pleased to present ADAPT 2009, Accelerating Development & Advancing Personalized Therapy. This event features eight meetings with in-depth coverage of Clinical Trials, Personalized Medicine, Cancer Therapy, and Biomarker Development. This event was developed as the primary platform where these currently disparate groups can come together, advance therapeutics, as well as tackle the challenges of the inevitable next chapter, personalized medicine. From Global pharmaceutical companies to small biotechs, universities, hospitals, and individuals the need to ADAPT is imperative to survive and thrive in today’s...tomorrow’s marketplace. |
September 22: Pre-Conference Short Course
Biomarker Assay Development and Validation
|
Third Annual
Adaptive Clinical Trial Designs
Managing Complexity for Successful Implementation
September 22-24
|
Third Annual
Clinical Biomarkers
Optimizing Drug Development
September 24-25
|
|
September 22: Pre-Conference Short Course
Next-Generation Technologies Enabling Personalized Medicine
|
Inaugural
Personalized Medicine
Delivering on the Promise
September 22-24
|
Inaugural
Targeted Therapy
Towards Individualized Cancer Treatment
September 24-25
|
|
|
|
September 22: Pre-Conference Short Course
Biomarker Validation
|
Third Annual
Biomarker Data Analysis
Integrating Biomarker Data and Establishing Biological and Clinical Relevance
September 22-24
|
Seventh Annual
Protein Biomarkers
Overcoming Translational Challenges
September 24-25
|
KEYNOTE SPEAKERS:
 J. Carl Barrett
VP and Global Head
Oncology Translational Medicine, Novartis
|
 Nicholas C. Dracopoli
VP, Biomarkers, Centocor R&D
Johnson & Johnson
|
AVP, Head, Discovery Translational Medicine
Wyeth Research
|
 Stephen H. Friend
President
Sage
|
 Mark J. Ratain
Chairman, Clinical Pharmacology and
Pharmacogenomics
Cancer Research Center, Univ. Chicago
|
 Allen D. Roses
Director, Deane Drug Discovery Institute
Duke Univ. School of Medicine
|
 Douglas C. Throckmorton
Deputy Director, Center for Drug Evaluation and Research
U.S. Food and Drug
Administration
|
|
|
|
For more information, please contact:
Julia Boguslavsky, Executive Director, Conferences
E-mail: juliab@healthtech.com
For sponsorship information, please contact:
Ilana Quigley, Business Development
Phone: 781-972-5457; E-mail: iquigley@healthtech.com